Dow Jones

39,872.99

0.17%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

VOR

Vor Biopharma (VOR)

Vor Biopharma Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VOR

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
09/05/2024	15:05	GlobeNewswire Inc.	Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
09/05/2024	15:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VOR	Vor Biopharma Inc
07/05/2024	15:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
06/05/2024	07:00	GlobeNewswire Inc.	Vor Bio to Participate in Upcoming Investor Conferences	NASDAQ:VOR	Vor Biopharma Inc
03/05/2024	15:01	GlobeNewswire Inc.	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VOR	Vor Biopharma Inc
02/05/2024	15:01	GlobeNewswire Inc.	Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors	NASDAQ:VOR	Vor Biopharma Inc
20/03/2024	15:05	GlobeNewswire Inc.	Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
14/02/2024	15:08	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:VOR	Vor Biopharma Inc
07/02/2024	07:00	GlobeNewswire Inc.	Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:VOR	Vor Biopharma Inc
17/01/2024	15:01	GlobeNewswire Inc.	Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update	NASDAQ:VOR	Vor Biopharma Inc
05/01/2024	16:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VOR	Vor Biopharma Inc
27/11/2023	07:00	GlobeNewswire Inc.	Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit	NASDAQ:VOR	Vor Biopharma Inc
09/11/2023	15:01	GlobeNewswire Inc.	Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference	NASDAQ:VOR	Vor Biopharma Inc
07/11/2023	15:05	GlobeNewswire Inc.	Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
02/11/2023	08:01	GlobeNewswire Inc.	Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio’s Novel eHSC and CAR-T Platform	NASDAQ:VOR	Vor Biopharma Inc
30/08/2023	15:51	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:VOR	Vor Biopharma Inc
10/08/2023	15:05	GlobeNewswire Inc.	Vor Bio Reports Second Quarter 2023 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
01/08/2023	07:00	GlobeNewswire Inc.	Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference	NASDAQ:VOR	Vor Biopharma Inc
09/06/2023	06:42	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VOR	Vor Biopharma Inc
09/06/2023	06:30	GlobeNewswire Inc.	Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio’s Platform	NASDAQ:VOR	Vor Biopharma Inc
05/06/2023	07:00	GlobeNewswire Inc.	Vor Bio to Participate in the Goldman Sachs Healthcare Conference	NASDAQ:VOR	Vor Biopharma Inc
02/06/2023	15:40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VOR	Vor Biopharma Inc
11/05/2023	15:05	GlobeNewswire Inc.	Vor Bio Reports First Quarter 2023 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
14/04/2023	15:05	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:VOR	Vor Biopharma Inc
23/03/2023	15:01	GlobeNewswire Inc.	Vor Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
16/02/2023	11:00	GlobeNewswire Inc.	First AML Patient Transplanted with Vor Bio’s Trem-cel Demonstrated Durable Engraftment through Multiple Mylotarg™ Cycles at Initial Dose Level	NASDAQ:VOR	Vor Biopharma Inc
19/01/2023	07:00	GlobeNewswire Inc.	Vor Bio to Present Clinical Data from First Patient Treated with Trem-cel at 2023 Tandem Meetings	NASDAQ:VOR	Vor Biopharma Inc
12/01/2023	07:00	GlobeNewswire Inc.	Vor Bio to Present at B. Riley Securities’ 3rd Annual Oncology Conference	NASDAQ:VOR	Vor Biopharma Inc
10/01/2023	11:49	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VOR	Vor Biopharma Inc
23/12/2022	15:06	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:VOR	Vor Biopharma Inc